Finance institute forecasts net capital outflow from emerging markets for first time since 1988 leaving states vulnerable to ‘capital drought’
Global investors will suck capital out of emerging economies this year for the first time since...
Last month, names like Sanofi, Pfizer, Abbott and Takeda were flying around as potential suitors for Mexico-based Representaciones e Investigaciones Medicas, aka Rimsa. But it's Teva that's emerged victorious in the field.
Factories in Asia cut more jobs and throttled back output in September as domestic and export demand shrivelled, adding to fears that cooling growth in China and emerging markets will jeopardize an increasingly fragile global recovery.